Stock listing
Frankfurt:V59 Xuanzhu Biopharmaceutical Co., Ltd. Aktie
German listing (Frankfurt) of Xuanzhu Biopharmaceutical Co., Ltd. · home listing HKEX:2575
Follow Xuanzhu Biopharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Home listing price · HKEX:2575
$8.11 HKD +0.38 (+4.9%)
Close on Nov 3, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:2575
- Day range
- $7.75 – $9.49 HKDNov 3, 2026
- Volume
- 7.57M sharesNov 3, 2026
- Market cap
- $4.20B HKDAt the close on Nov 3, 2026 · price × 517.9M shares outstanding
- 52-week range
- $7.52 – $96.90 HKDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $18.99M HKDMedian day 763,504 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:2575 · Home | $8.105 HKD | +0.375 (+4.9%) | 7,570,000 | $8.08 | $9.49 | $7.745 | $7.73 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · HKEX:2575 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.105 | +0.375 | +4.9% | $8.08 | $9.49 | $7.745 | 7,570,000 | |
| $7.73 | -0.87 | -10.1% | $8.595 | $8.875 | $7.52 | 1,821,000 | |
| $8.60 | +0.055 | +0.6% | $8.65 | $9.01 | $8.55 | 1,656,668 | |
| $8.545 | -0.01 | -0.1% | $8.72 | $8.795 | $8.34 | 1,132,000 | |
| $8.555 | +0.05 | +0.6% | $8.50 | $8.67 | $8.27 | 608,000 | |
| $8.505 | +0.03 | +0.4% | $8.79 | $9.30 | $8.325 | 2,427,000 | |
| $8.475 | +0.225 | +2.7% | $8.50 | $8.72 | $8.115 | 731,200 | |
| $8.25 | -0.05 | -0.6% | $8.30 | $8.515 | $8.10 | 753,000 | |
| $8.30 | -0.26 | -3.0% | $8.695 | $8.71 | $8.21 | 1,010,000 | |
| $8.56 | +0.27 | +3.3% | $8.29 | $8.68 | $8.285 | 960,000 | |
| $8.29 | +0.01 | +0.1% | $8.205 | $8.52 | $8.205 | 708,500 | |
| $8.28 | -0.135 | -1.6% | $9.00 | $9.00 | $8.185 | 2,411,500 | |
| $8.415 | +0.345 | +4.3% | $8.20 | $8.86 | $8.18 | 3,100,500 | |
| $8.07 | -0.215 | -2.6% | $8.135 | $8.50 | $8.05 | 2,187,000 | |
| $8.285 | -0.155 | -1.8% | $8.225 | $8.70 | $8.06 | 6,149,000 | |
| $8.44 | +0.065 | +0.8% | $8.33 | $8.82 | $8.20 | 921,000 | |
| $8.375 | -0.045 | -0.5% | $8.57 | $8.58 | $8.135 | 1,133,000 | |
| $8.42 | -0.015 | -0.2% | $8.855 | $9.58 | $8.18 | 3,880,000 | |
| $8.435 | -0.185 | -2.1% | $8.60 | $8.60 | $8.21 | 100,539 | |
| $8.62 | +0.045 | +0.5% | $8.70 | $8.87 | $8.62 | 155,003 | |
| $8.575 | -0.20 | -2.3% | $8.365 | $8.71 | $8.36 | 111,000 | |
| $8.775 | -0.525 | -5.6% | $9.20 | $9.20 | $8.605 | 170,000 | |
| $9.30 | +0.55 | +6.3% | $8.76 | $9.70 | $8.64 | 8,325,000 | |
| $8.75 | +0.65 | +8.0% | $8.25 | $10.05 | $8.05 | 13,526,986 | |
| $8.10 | -0.12 | -1.5% | $8.465 | $8.465 | $8.08 | 709,500 | |
| $8.22 | -0.075 | -0.9% | $8.25 | $8.315 | $8.18 | 18,500 | |
| $8.295 | -0.30 | -3.5% | $8.59 | $8.78 | $8.25 | 792,000 | |
| $8.595 | -0.12 | -1.4% | $8.905 | $8.905 | $8.485 | 1,456,000 | |
| $8.715 | -0.425 | -4.6% | $9.50 | $9.50 | $8.705 | 2,102,494 | |
| $9.14 | -0.115 | -1.2% | $9.255 | $9.695 | $9.125 | 3,494,500 | |
| $9.255 | +0.165 | +1.8% | $9.20 | $9.765 | $9.005 | 5,449,581 | |
| $9.09 | +0.96 | +11.8% | $8.13 | $11.72 | $8.13 | 19,121,992 | |
| $8.13 | -0.17 | -2.0% | $8.25 | $8.28 | $8.005 | 2,286,500 | |
| $8.30 | -0.18 | -2.1% | $8.62 | $8.74 | $8.105 | 361,000 | |
| $8.48 | -0.46 | -5.1% | $8.94 | $9.25 | $8.405 | 711,000 | |
| $8.94 | +0.06 | +0.7% | $8.875 | $8.94 | $8.005 | 1,972,000 | |
| $8.88 | -0.685 | -7.2% | $9.50 | $9.555 | $8.765 | 1,365,500 | |
| $9.565 | -0.335 | -3.4% | $10.31 | $10.31 | $9.20 | 1,676,700 | |
| $9.90 | +0.10 | +1.0% | $9.855 | $10.58 | $9.795 | 2,141,500 | |
| $9.80 | -0.63 | -6.0% | $10.46 | $10.46 | $9.70 | 2,078,500 | |
| $10.43 | -0.69 | -6.2% | $11.30 | $11.80 | $10.40 | 4,328,378 | |
| $11.12 | +1.715 | +18.2% | $9.80 | $13.40 | $9.45 | 12,461,000 | |
| $9.405 | -0.195 | -2.0% | $9.90 | $9.90 | $9.315 | 399,500 | |
| $9.60 | -0.48 | -4.8% | $10.11 | $10.19 | $9.60 | 393,000 | |
| $10.08 | -0.49 | -4.6% | $10.50 | $10.50 | $9.935 | 435,500 | |
| $10.57 | +0.01 | +0.1% | $10.38 | $10.89 | $10.38 | 389,500 | |
| $10.56 | -0.17 | -1.6% | $10.74 | $10.99 | $10.35 | 296,500 | |
| $10.73 | +0.22 | +2.1% | $10.70 | $11.57 | $10.67 | 901,000 | |
| $10.51 | +0.17 | +1.6% | $10.37 | $10.94 | $10.36 | 394,500 | |
| $10.34 | -0.72 | -6.5% | $11.50 | $11.50 | $10.25 | 348,500 | |
| $11.06 | -0.04 | -0.4% | $11.50 | $11.50 | $11.00 | 301,000 | |
| $11.10 | -0.23 | -2.0% | $11.79 | $12.39 | $11.10 | 763,504 | |
| $11.33 | -0.97 | -7.9% | $12.19 | $12.19 | $11.25 | 289,500 | |
| $12.30 | -0.08 | -0.6% | $12.31 | $12.83 | $12.25 | 272,746 | |
| $12.38 | +0.02 | +0.2% | $12.16 | $12.63 | $12.16 | 98,500 | |
| $12.36 | -0.03 | -0.2% | $12.39 | $13.00 | $12.13 | 184,277 | |
| $12.39 | -0.56 | -4.3% | $13.19 | $13.19 | $12.33 | 489,500 | |
| $12.95 | +0.04 | +0.3% | $12.92 | $13.10 | $12.67 | 202,071 | |
| $12.91 | +0.03 | +0.2% | $12.88 | $13.10 | $12.53 | 214,965 | |
| $12.88 | +0.40 | +3.2% | $12.70 | $13.45 | $12.54 | 488,500 | |
| $12.48 | +0.39 | +3.2% | $12.09 | $12.65 | $11.88 | 398,489 | |
| $12.09 | -0.21 | -1.7% | $12.43 | $12.78 | $11.84 | 393,500 | |
| $12.30 | +0.50 | +4.2% | $11.81 | $13.17 | $11.80 | 1,198,000 | |
| $11.80 | +0.22 | +1.9% | $11.70 | $12.16 | $11.70 | 399,000 | |
| $11.58 | +0.59 | +5.4% | $10.99 | $11.63 | $10.92 | 494,453 |
- Ticker
- Frankfurt:V59
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news
Voluntary announcement phase III clinical study data of Anaprazole Sodium for reflux esophagitis presented at UEG Week 2026PRESENTED at UEG Week 2026
Oct 21, 2026
Closed $8.30 (-3.0%) on Oct 22, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Oct 7, 2026
Closed $8.42 (-0.2%) on Oct 8, 2026
Voluntary announcement unusual price movements
Sep 17, 2026
Closed $9.26 (+1.8%) on Sep 18, 2026
2025 Annual report - supplemental information
Sep 16, 2026
Closed $9.09 (+11.8%) on Sep 17, 2026
2026 Interim report
Sep 16, 2026
Closed $9.09 (+11.8%) on Sep 17, 2026
Voluntary announcement first patient enrolled in phase III clinical trial of anaprazole sodium for helicobacter pylori eradication
Jun 21, 2026
Closed $16.30 (-2.7%) on Jun 22, 2026
List of directors and their role and function
Jun 18, 2026
Closed $16.30 (-2.7%) on Jun 22, 2026
Xuanzhu Biopharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 7 in the last 12 months · 7 in all · newest Oct 21, 2026 · oldest 2026
Where Xuanzhu Biopharmaceutical Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:2575 軒竹生物 · Home listing | HKEX | Hong Kong | HKD |
| Frankfurt:V59 · This page | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Xuanzhu Biopharmaceutical Co., Ltd.